Biodistribution and pharmacokinetics of aerosol and intravenously administered dna–polyethyleneimine complexes: optimization of pulmonary delivery and retention
Open Access
- 1 August 2003
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 8 (2) , 249-254
- https://doi.org/10.1016/s1525-0016(03)00177-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Proteolipidic Vectors for Gene Transfer to the LungBiochemical and Biophysical Research Communications, 2002
- Aerosol delivery of PEI–p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesisCancer Gene Therapy, 2002
- Transgene Expression in Mouse Airway Epithelium by Aerosol Gene Therapy with PEI–DNA ComplexesMolecular Therapy, 2001
- Pulmonary cytokine responses associated with PEI–DNA aerosol gene therapyGene Therapy, 2001
- Inhibition of Experimental Lung Metastasis by Aerosol Delivery of PEI–p53 ComplexesMolecular Therapy, 2000
- Enhanced Gene Expression in Mouse Lung after PEI–DNA Aerosol DeliveryMolecular Therapy, 2000
- Aerosol Delivery of Robust Polyethyleneimine– DNA Complexes for Gene Therapy and Genetic ImmunizationMolecular Therapy, 2000
- Gene transfer by guanidinium-cholesterol: dioleoylphosphatidyl-ethanolamine liposome-DNA complexes in aerosolThe Journal of Gene Medicine, 1999
- Ultrasonic Nebulization of Cationic Lipid-Based Gene Delivery Systems for Airway AdministrationPharmaceutical Research, 1998
- A Concentrated and Stable Aerosol Formulation of Cationic Lipid:DNA Complexes Giving High-Level Gene Expression in Mouse LungHuman Gene Therapy, 1997